Seres Therapeutics, Inc. · NASDAQ:MCRB
Shaff Eric D. sold 259 Seres Therapeutics, Inc. shares (Form 4)
Traded May 15 to May 18, 2026 · Filed May 19, 2026
From May 15 to May 18, 2026, Shaff Eric D. (Director) sold 259 Seres Therapeutics, Inc. shares at US$7.53 for US$1,950 under a trading plan, leaving 12,040 shares. Filed May 19, 2026 (Form 4).
- Sold
- 259 shares
- Price
- US$7.53
- Value
- US$1,950
- Holding after
- 12,040 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Option exercise | 722 | 12,299 | Direct | |
| May 18, 2026 | Common Stock | Sale | 259 | US$7.53 | 12,040 | Direct |